ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-27130

Dokploy is a free, self-hostable Platform as a Service (PaaS).

Published May 18, 2026 · catalog updated Oct 6, 2026 · Dokploy is a free,

Check if you run it

No confirmed exploitation is on record for CVE-2026-27130. EPSS is 1.22%. Act only if a listed version of Dokploy is a free, is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Dokploy is a free,).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.9
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
1.22%
Remediation
Advisory link
Affected products
See sources for product scope

Dokploy is a free, self-hostable Platform as a Service (PaaS). Versions 0.26.6 and below have OS command injection through the appName parameter. 3 chained issues cause this problem: inadequate input sanitization, lack of schema validation and direct shell interpolation. User-controlled application names are passed through inadequate sanitization (cleanAppName function only replaces spaces and converts to lowercase) before being interpolated directly into shell commands executed via execAsync() and execAsyncRemote(). An authenticated attacker can inject shell metacharacters (e.g., ;, $(), backticks, |, &) in the appName field during application creation, which are then executed with server-level privileges when service operations (start, stop, remove, scale) are triggered. This issue has been resolved in version 0.26.7.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-27130

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-27130. EPSS is 1.22%. Act only if a listed version of Dokploy is a free, is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-78: OS Command Injection. EPSS 1.22%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. May 18, 2026 · NIST NVD

    Detected

    Dokploy is a free, self-hostable Platform as a Service (PaaS). Versions 0.26.6 and below have OS command injection through the appName parameter. 3 chained issues cause this problem: inadequate input sanitization, lack of schema validation and direct shell interpolation. User-controlled application names are passed through inadequate sanitization (cleanAppName function only replaces spaces and con

  2. Oct 6, 2026 · NIST NVD

    Updated

    Dokploy is a free, self-hostable Platform as a Service (PaaS). Versions 0.26.6 and below have OS command injection through the appName parameter. 3 chained issues cause this problem: inadequate input sanitization, lack of schema validation and direct shell interpolation. User-controlled application names are passed through inadequate sanitization (cleanAppName function only replaces spaces and con

Sources

  • CVE.orgVulnerability recordCVE-2026-27130

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-27130

    30-day exploitation probability 1.2%

    first.org
  • NIST NVDVulnerability recordCVE-2026-27130

    Dokploy is a free, self-hostable Platform as a Service (PaaS). Versions 0.26.6 and below have OS command injection through the appName parameter. 3 chained issues cause this problem: inadequate input sanitization, lack of schema validation and direct shell interpolation. User-con

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.